Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1281111.RAHG_v4DbEnck4XmdwqcjCTEhMoBcthvErama2qtOtjG0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1281111.RAHG_v4DbEnck4XmdwqcjCTEhMoBcthvErama2qtOtjG0130_assertion type Assertion NP1281111.RAHG_v4DbEnck4XmdwqcjCTEhMoBcthvErama2qtOtjG0130_head.
- NP1281111.RAHG_v4DbEnck4XmdwqcjCTEhMoBcthvErama2qtOtjG0130_assertion description "[It represents a potential therapeutic option against LM after failure of standard-dose EGFR-TKIs, especially to palliate LM-related neurological symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1281111.RAHG_v4DbEnck4XmdwqcjCTEhMoBcthvErama2qtOtjG0130_provenance.
- NP1281111.RAHG_v4DbEnck4XmdwqcjCTEhMoBcthvErama2qtOtjG0130_assertion evidence source_evidence_literature NP1281111.RAHG_v4DbEnck4XmdwqcjCTEhMoBcthvErama2qtOtjG0130_provenance.
- NP1281111.RAHG_v4DbEnck4XmdwqcjCTEhMoBcthvErama2qtOtjG0130_assertion SIO_000772 25921002 NP1281111.RAHG_v4DbEnck4XmdwqcjCTEhMoBcthvErama2qtOtjG0130_provenance.
- NP1281111.RAHG_v4DbEnck4XmdwqcjCTEhMoBcthvErama2qtOtjG0130_assertion wasDerivedFrom befree-2016 NP1281111.RAHG_v4DbEnck4XmdwqcjCTEhMoBcthvErama2qtOtjG0130_provenance.
- NP1281111.RAHG_v4DbEnck4XmdwqcjCTEhMoBcthvErama2qtOtjG0130_assertion wasGeneratedBy ECO_0000203 NP1281111.RAHG_v4DbEnck4XmdwqcjCTEhMoBcthvErama2qtOtjG0130_provenance.